Shares Issued
The Company’s issued share capital consists of 129,149,998 ordinary shares of one penny par value.
The Company’s shares are traded on the London Stock Exchange under the ticker code ROQ and on the OTCQB Venture Market in the USA with the ticker code ROQAF
Major Shareholders of the Company
Roquefort Therapeutics is aware of the following persons who hold, directly or indirectly, voting rights representing 3% or more of the issued share capital of the Company to which voting rights are attached:
Name | Shares | % |
|---|---|---|
A Reginald | 11,663,051 | 9.0 |
A Lachab | 7,750,000 | 6.0 |
J Whiddon* | 7,300,000 | 5.7 |
M Sheikh | 5,744,870 | 4.4 |
S West** | 5,616,501 | 4.3 |
Provelmare Holding Ltd | 5,000,000 | 3.9 |
Z Sheikh | 4,018,910 | 3.1 |
M Rollins | 4,000,000 | 3.1 |
K Fallon | 3,905,215 | 3.0 |
*2,500,000 shares held by MIMO Strategies Pty Ltd (ATF the MIMO Trust); 4,100,000 shares held by 6466 Investments Pty Ltd; 700,000 shares held by Nautical Holdings WA Pty Ltd – all of which are entities controlled by J Whiddon
**4,628,485 shares held by Cresthaven Investments Pty Ltd (ATF the Bellini Trust) – an entity associated with S West
Share Registry
Share Registrars Limited
27/28 Endcastle Street
London W1W 8DH
United Kingdom
Phone: +44 (0)1252 821 390
Email: enquiries@shareregistrars.uk.com